Navigation Links
Response Biomedical Corporation Reports 2008 Financial Results
Date:3/30/2009

s. We successfully moved into a state-of-the-art manufacturing facility on March 31, 2008. The facility is essential for supplying the expected volume of quality products to our partners and for reducing our manufacturing costs. The facility successfully completed a FDA Quality System Inspection Technique (QSIT) Audit in the third quarter of 2008. We believe it is imperative that we continue to focus on building the business that will sustain the Company moving forward and the market will ultimately recognize and reward these efforts."

"In 2009, we are focused on execution; especially in meeting the requirements for the Roche launch of our cardiovascular product line," continued Mr Kay. "While the state of the capital markets creates significant uncertainty, we are actively pursuing financing alternatives to fund our working capital and other business needs. We have completed the clinical trials for our RSV Test for 3M, and we are preparing the data to submit for regulatory clearance to the FDA. We are hopeful that we will have that clearance and launch the RSV Test toward the end of 2009, during the next RSV/Flu season. Additionally, Roche is funding work for a next generation Troponin-I assay and a CLIA-waiver trial for NT-proBNP. This work is a key focus for the Company in 2009. We are also continuing discussions with other potential partners for additional applications of the RAMP(R) technology, which we hope to garner during the year. It is definitely an exciting time for our Company and our stakeholders."

About Response Biomedical

Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP(R) Platform for clinical and environmental applications. RAMP(R) represents a new paradigm in diagnostics that provides high sensitivity and reliable information in minutes. It is ideally suited to both point of care testing and laboratory use.

The RAMP(R) system consists of a R
'/>"/>

SOURCE Response Biomedical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Tray-Pak Direct Mailer Garners 21% Response, Design Award
2. 2-day results predict ultimate response to therapy in chronic hepatitis C
3. In Hepatitis C Virus Treatment, Interviewed Experts Indicate That Telaprevir- and Boceprevir-Based Regimens Have Advantages Over Pegasys/Ribavirin in Sustained Virologic Response
4. Warner Chilcott Announces Receipt of FDA Response to Citizen Petition
5. New Study Shows Probiotic Strain Effective in Boosting Immune Response
6. Cell pathway on overdrive prevents cancer response to dietary restriction
7. Response Biomedical Named Medical Device Company of the Year by LifeSciences British Columbia
8. AdvaMed Response to the Medical Device Safety Act
9. Ethnicity May Drive Response to Obesity, Insulin Resistance
10. Study Showing Improved Virologic Response with Nitazoxanide in Chronic Hepatitis C Published in Gastroenterology
11. Preparing for the Next Disaster: Dialysis Community Briefs Hill About Emergency Response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... stems from discovery of mutation affecting infertility, , , THURSDAY, ... infertility in men could point the way to a ... , "We have identified CATSPER1 as a gene that ... finding which could lead to future infertility therapies that ...
... a computer based model that aids them in discriminating ... study performed at the University Of Wisconsin School of ... multidisciplinary group, including radiologists and industrial engineers, led by ... Chhatwal, PhD. , "The computer based ...
... When the need for speed is critical, how ... hospitals, sending alerts to help prevent or stop a ... providers be notified about disease outbreaks, illness from food ... , Researchers from the Regenstrief Institute, Inc. in collaboration ...
... to Help Healthcare Organizations Improve Access to ... Systems OutageWAYNE, Pa. and GREENWOOD VILLAGE, Colo., ... formed a partnership with Orchestrate Healthcare, a ... to help healthcare organizations improve information availability ...
... not been proven that long-acting insulin analogues (LAIAs) have an ... with type 2 diabetes. Even though the results of a ... assessed (insulin glargine), the potential long-term benefits and harms of ... is the conclusion of a report by the German Institute ...
... on the success of Mirixa Corporation in the ... available nationwide in Australia GOLD COAST, Queensland, ... leader in pharmacy-based patient care services and the ... of Mirixa Australia at the Australian Pharmacy Professional ...
Cached Medicine News:Health News:Genetic Finding May Lead to Male Contraceptive 2Health News:Computer based model helps radiologists diagnose breast cancer 2Health News:Getting the word out when the need for speed is critical to public health 2Health News:Getting the word out when the need for speed is critical to public health 3Health News:SunGard Availability Services Partners with Orchestrate Healthcare to Improve Availability of Electronic Medical Records 2Health News:SunGard Availability Services Partners with Orchestrate Healthcare to Improve Availability of Electronic Medical Records 3Health News:SunGard Availability Services Partners with Orchestrate Healthcare to Improve Availability of Electronic Medical Records 4Health News:Long-acting insulin analogues in type 2 diabetes: advantage over human insulin not proven 2Health News:Long-acting insulin analogues in type 2 diabetes: advantage over human insulin not proven 3Health News:Long-acting insulin analogues in type 2 diabetes: advantage over human insulin not proven 4Health News:Mirixa Australia Launches at APP2009 2Health News:Mirixa Australia Launches at APP2009 3
(Date:1/14/2014)... HILLSBORO, Ore. , Jan. 14, 2014 /PRNewswire-iReach/ -- ... and a targeting guide with accompanying instrumentation to place ... new adjunct to the soft tissue (e.g. ligament) repair ... soft tissue repair heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ... to maintain the anatomical reduction (spacing) of the scaphoid ...
(Date:1/14/2014)... , Jan. 14, 2014 NineSigma , ... hold its Innovation Leadership Summit , May 14-16, ... Cleveland Ohio . ... and organizations committed to breakthrough achievements through open innovation. ... through unobvious connections, across disciplines and even across industries. ...
(Date:1/14/2014)... 14, 2014   Evidera , a leading ... announced that the Center for Drug Evaluation and ... released its first draft qualification guidance document for ... Qualification of Exacerbations of Chronic Pulmonary Disease ... Bacterial Exacerbation of Chronic Bronchitis in Patients With ...
Breaking Medicine Technology:Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
... CHICAGO, Oct. 7 A new women,s health, whole ... frequency of moderate to severe hot flashes and reduced ... its kind among postmenopausal U.S. women, according to peer-reviewed ... American Menopause Society (NAMS) Annual Meeting.  Also, the first ...
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) ... Application (NDA) filing for carfilzomib based on a recent ... division of the U.S. Food and Drug Administration (FDA). ... commercial-scale manufacturing of carfilzomib.  Onyx had previously anticipated filing ...
Cached Medicine Technology:New Soy-Based Natural S-equol Supplement Reduces Menopausal Hot Flashes, Muscle and Joint Pain in First Study Among U.S. Women 2New Soy-Based Natural S-equol Supplement Reduces Menopausal Hot Flashes, Muscle and Joint Pain in First Study Among U.S. Women 3New Soy-Based Natural S-equol Supplement Reduces Menopausal Hot Flashes, Muscle and Joint Pain in First Study Among U.S. Women 4New Soy-Based Natural S-equol Supplement Reduces Menopausal Hot Flashes, Muscle and Joint Pain in First Study Among U.S. Women 5New Soy-Based Natural S-equol Supplement Reduces Menopausal Hot Flashes, Muscle and Joint Pain in First Study Among U.S. Women 6New Soy-Based Natural S-equol Supplement Reduces Menopausal Hot Flashes, Muscle and Joint Pain in First Study Among U.S. Women 7Onyx Pharmaceuticals Provides Status Update on Carfilzomib 2Onyx Pharmaceuticals Provides Status Update on Carfilzomib 3
... System supports approaches to Admitting/Discharge/Transfer ... record keeping functions using a ... facilities and cut across institutional ... community clinics, physician, agency, nursing ...
... Dairylands Clinical Information Management ... suite of integrated applications ... departments and automate administrative ... The applications allow organizations ...
... include a Patient Face Sheet, ... many as six custom tabs, ... information is important for you ... Import Manager utility lets you ...
... WEBeDoctor® Physician-office® is an ... physicians, (Solo practice, group ... to complete their normal ... It is a front ...
Medicine Products: